Skip to main content
Article
Preoperative serum TA90-IC as an adjunct to serum CA 19-9 in the diagnosis of pancreatic malignancy: A pilot study
Current Surgery (2002)
  • Mathew H. Chung, The Roy E. Coats Research Laboratories of the John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, California, USA
  • Rishab K. Gupta, The Roy E. Coats Research Laboratories of the John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, California, USA
  • Anton J. Bilchik, The Roy E. Coats Research Laboratories of the John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, California, USA
  • Wei. Ye, The Roy E. Coats Research Laboratories of the John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, California, USA
  • Reynold Yee, The Roy E. Coats Research Laboratories of the John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, California, USA
  • Donald L. Morton, The Roy E. Coats Research Laboratories of the John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, California, USA
Publication Date
March 1, 2002
DOI
10.1016/S0149-7944(01)00594-3
Citation Information
Mathew H. Chung, Rishab K. Gupta, Anton J. Bilchik, Wei. Ye, et al.. "Preoperative serum TA90-IC as an adjunct to serum CA 19-9 in the diagnosis of pancreatic malignancy: A pilot study" Current Surgery Vol. 59 Iss. 2 (2002) p. 194 - 198
Available at: http://works.bepress.com/antonj-bilchik/181/